Biological Information
Background Information:
PDE4C1, isoform of cAMP-specific 3',5'-cyclic phosphodiesterase 4C, is expressed in different organs including brain, liver, lung, kidney and heart. Selective inhibitors of PDE4 subtypes may be useful to treat a wide variety of disorders such as asthma, COPD, inflammatory, neurological disorders.
Family:
PDE
Sub Family:
Phosphodiesterase
Class:
Cyclic Nucleotide Signaling
Protein Name:
PDE4C
Uniprot Number:
Q08493
Protein Aliases:
DPDE1/ PDE21
Gene Name:
PDE4C
Gene ID:
5143
Gene Aliases:
DPDE1
Accession Number:
NM_000923
Organism:
Human
Construct Details:
Full Length, Recombinant
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Enzymatic
Functional Mode:
Antagonist
Detection Method:
Fluorescence Polarization
Measured Response:
Fluorescence
Testing Information
Procedure Summary:
Human recombinant PDE4C1 expressed in insect Sf9 cells are used. Test compound and/or vehicle is preincubated with 8 ng/ml enzymeǂ in Tris-HCl buffer pH 7.2 for 15 minutes at 25°C. The reaction is initiated by addition of 100 nM FAM-cAMP for another 30 minutes incubation period and terminated by addition of IMAP binding solution. IMAP complexes with phosphate groups on nucleotide monophosphate generated from cyclic nucleotides through PDE activity. Determination of the amount of complex formed is read spectrofluorimetrically at 470 nm/525 nm. Compounds are screened at 10 μM.
Substrate:
0.1 µM FAM-cAMP
Incubation:
30 min at 25°C
Control Inhibitor:
Rolipram
Criteria For Significance:
≥ 50% of max stimulation or inhibition
Test Concentration / Dose:
Suggested concentration for initial testing is 10 uM
Test Sample Requirements:
Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).
Minimum Order Quantity:
2
Turnaround Time
Standard:
15 Business Days
Reference Compound Data
Clinical Relevance
Therapeutic Area:
Pulmonology
Additional Information
Brand:
LeadHunter
Testing Location:
Taiwan - Taipei
RELATED SOLUTIONS